Leading cardiologists at The Mount Sinai Hospital have contributed to the development of a new classification system called MOGE(S) for cardiomyopathies, the diseases of the heart muscle which can ...

Leading cardiologists have contributed to the development of a new classification system called MOGE(S) for cardiomyopathies, the diseases of the heart muscle which can lead to heart enlargement and ...

When Kristen Criss was diagnosed with hypertrophic cardiomyopathy (HCM), it felt like the pieces of her family's health puzzle had finally fallen into place. "My mom passed at 40-years-old, and my ...

The emergence of novel pharmacotherapies, minimally-invasive procedures and gene-directed approaches shall fundamentally alter the Hypertrophic Cardiomyopathy therapeutic landscape. Amongst all ...

A CNIC team has designed a gene-therapy strategy that could transform the treatment of arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5), a rare and deadly heritable disease that ...

Attruby is the first near-complete (≥90%) stabilizer of Transthyretin (TTR) approved in the U.S. for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis ...

Hypertrophic cardiomyopathy (HCM) makes it difficult for your heart to pump blood normally due to a thickening and enlargement of the heart muscle. This can block the ventricles in the lower heart, ...

Baltimore, MD - Pulmonary hypertension is known to be a reliable predictor of death in heart failure (HF) patients whose disease arises from both ischemic and nonischemic circumstances. Now, a study ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In certain patients with an ICD for primary prevention, ...